A Alt

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro
    A Alt
    Lilly Research Laboratories, Eli Lilly and Company, Neuroscience Discovery Research, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Neuropharmacology 46:793-806. 2004
  2. ncbi request reprint AMPA receptor potentiators as novel antidepressants
    A Alt
    Eli Lilly and Company, Neuroscience Discovery Research, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Curr Pharm Des 11:1511-27. 2005
  3. ncbi request reprint AMPA receptors in the therapeutic management of depression
    D Bleakman
    Eli Lilly and Company, Neuroscience Discovery Research, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    CNS Neurol Disord Drug Targets 6:117-26. 2007
  4. ncbi request reprint Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle
    L Braiman
    Faculty of Life Sciences, Gonda Goldschmied Center Bar Ilan University, Ramat Gan 52900, Israel
    Mol Endocrinol 15:565-74. 2001

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro
    A Alt
    Lilly Research Laboratories, Eli Lilly and Company, Neuroscience Discovery Research, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Neuropharmacology 46:793-806. 2004
    ....
  2. ncbi request reprint AMPA receptor potentiators as novel antidepressants
    A Alt
    Eli Lilly and Company, Neuroscience Discovery Research, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Curr Pharm Des 11:1511-27. 2005
    ..Although these effects are also produced by traditional antidepressants, AMPA receptor potentiators appear to produce their effects through a novel mechanism...
  3. ncbi request reprint AMPA receptors in the therapeutic management of depression
    D Bleakman
    Eli Lilly and Company, Neuroscience Discovery Research, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    CNS Neurol Disord Drug Targets 6:117-26. 2007
    ..Combined, these data suggest that AMPA receptors may be in a key position to regulate mood disorders, and that compounds which target AMPA receptors may prove useful in the clinical management of depression...
  4. ncbi request reprint Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle
    L Braiman
    Faculty of Life Sciences, Gonda Goldschmied Center Bar Ilan University, Ramat Gan 52900, Israel
    Mol Endocrinol 15:565-74. 2001
    ..We conclude that PKC delta is involved in regulation of IR activity and routing, and this regulation may be important in subsequent steps in the IR signaling cascade...